The field of regenerative medicine is an up and coming new approach of targeting and treating diseases, it involves the repair and restoration of previously damaged tissues or organs in the body. The regenerative medicine market was worth $16bn in 2013 and industry analysts predict that this will leap to over $60bn by 2020. The idea of regenerating tissues has caused much excitement, as it offers huge potential to change the face of medicine. Read the full story

The Regenerative Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies. Read the full story

Stemgent has completed the sale of its stem cell reagents and services business to ReproCELL in a cash transaction for approximately $8.5 million. Read the full story

NUI Galway and the Mayo Clinic in the US plan to collaborate on clinical trials using regenerative medicine, following the signing of a memorandum of understanding between the two institutes. Read the full story

Stem cells are cells found in all multicellular organisms, that can divide and differentiate into diverse specialized... Read the full story

Regenerative medicine is the process of replacing or regenerating human cells, tissues or organs to... Read the full story

Bioheart has entered into a joint venture with Magnum Cell Therapies. Read the full story

Histogenics Corporation announced the completion of a $49 million round of financing.

Read the full story